leisure time -WSS

leisure time

author：entertainment 2025-09-06 06:16:39 - browse：6

ACT UP protest — A demonstration marking the 10th anniversary of the formation ACT UP, in New York. Mark Lennihan/AP

WASHINGTON — Next Wednesday, a cadre of ALS patients will gather for a protest outside the FDA’s headquarters in suburban Maryland with a clear message: “No More Excuses.”

The rally is being organized by a ragtag group of ALS patients who connected mostly through Facebook, and it’s far less a production than other efforts like the 2014 ice bucket challenge that swept around the world.

These protesters haven’t even established a formal organization or a website; some said they’ve never even been to a protest. There’s nary a poster board in sight, yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

focus

WSS

Citing H5N1 threat, CDC urges peak flu monitoring this summer

In search for therapies for solid tumors, companies turn to claudin

An inside look at PIPEs, biotech's buzzy new financing tool

RSV vaccines may be linked to small increased risk of developing GBS

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

House looks to weaken Medicare negotiation

leisure time

leisure time

focus

The high cost of giving birth even with insurance

Fentanyl is making it harder to start addiction treatment

Trump demands the U.S. pay no more for drugs than other countries … again

H5N1 bird flu outbreak: Second human case reported, in Michigan

Alkermes shareholders re

International team creates first chimeric human

Duchenne breakthrough therapy leaves behind pioneering families

Medical device lobby: We're tired of waiting on Medicare coverage

At least 13 dead in Texas as scorching temps continue

FDA does about

knowledge

Study finds gene variants tied to breast cancer risk in Black women

Clinical trials giant ICON acquires HumanFirst

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Scrutiny of post

Listen: More tumult at BIO & coercive care for sickle cell patients

ASCO eve: Let’s set the table for this year's meeting

hotspot

hotspot

focus

entertainment